American Heart Association (AHA) released a scientific statement Feb. 1, 2018, linking breast cancer and cardiovascular disease.
Cardio-oncology
This channel includes news and new technology innovations about cardio oncology, the subspeciality of monitoring, preventing and treating cardiovascular damage caused by cancer treatments such as chemotherapy and radiation therapy. Chemo and radiation can damage or kill cardiac muscle cells, which can result in reduced cardiac pumping capacity. The speciality of cardio-oncology monitors cardiac performance with a baseline echocardiogram and followup imaging during treatments to ensure the heart is not damaged.
-
-
-
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a...
-
Interview with Federico Asch, M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at...
News | Cardiovascular Ultrasound | June 19, 2018
June 19, 2018 — Clinical practice, along with guidelines and research, have shown that speckle tracking...
News | Cardio-oncology | March 14, 2018
March 14, 2018 — After six months of follow-up, women newly diagnosed with...
News | Cardio-oncology | March 01, 2018
March 1, 2018 – Patients who were treated for breast cancer or lymphoma are more than three times at risk for...
News | Cardio-oncology | February 06, 2018
February 6, 2018 — High exposure to radiofrequency radiation (RFR) in rodents resulted in...
Videos | Cardio-oncology | February 01, 2018
American Heart Association (AHA) released a scientific statement Feb. 1, 2018, linking breast cancer and...
Laxmi Mehta, M.D., reviews an echocardiogram at The Ohio State Wexner Medical Center. She is calling for more research and collaboration to examine the link between heart disease and breast cancer to develop new treatments and preventative measures.
Feature | Cardio-oncology | February 01, 2018
February 1, 2018 – Heart disease and breast cancer are two of the most prevalent diseases among women in the United...
News | Cardio-oncology | September 26, 2017
September 26, 2017 — Treatment of heart attack patients depends on their history of...
News | Cardio-oncology | June 15, 2017
June 15, 2017 – Children who have suffered from cancer may also have lasting side effects from the drugs used in...
Tucker Roussin, 3, is the first survivor of fetal surgery for a life-threatening tumor connected to his heart. Fetal medicine experts at Children's Hospital of Philadelphia successfully removed this tumor. Credit: Children’s Hospital of Philadelphia.
News | Congenital Heart | October 28, 2016
October 28, 2016 — For the first time, fetal medicine experts have performed prenatal...
News | Cardio-oncology | September 28, 2016
September 28, 2016 — In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy...
The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves.
Feature | August 05, 2016 | Dave Fornell
August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...
